FDA Clearance Tracker · P030017-S300
Precision, Precision Spectra, Precision Novi, Precision Montage, Precision Montage MRI and Spectra WaveWriter Spinal Cor
Last checked: Nov 20, 2026Latest source record: Jan 19, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jan 19, 2018
Approved
Time to decision
205 days
Received Jun 28, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030017-S300
- Device name
- Precision, Precision Spectra, Precision Novi, Precision Montage, Precision Montage MRI and Spectra WaveWriter Spinal Cor
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Jun 28, 2017
- Decided
- Jan 19, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P030017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the addition of an alternate Ethylene Oxide sterilization site at the Boston Scientific St. Paul manufacturing site at 4100 Hamline Avenue North, St. Paul, Minnesota and new sterilization cycle parameters for that facility.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.